1. Home
  2. NMRA
  3. NMRA News

Latest Neumora Therapeutics Inc. (NMRA) News on November 9, 2025

MapLight Therapeutics, Gold Royalty, and More Stocks See Action From Activist Investors
NMRA

Barrons.com

a day ago

MapLight Therapeutics, Gold Royalty, and More Stocks See Action From Activist Investors

Neumora Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
NMRA

GlobeNewswire

3 days ago

Neumora Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Neumora Therapeutics to Participate in Upcoming Conferences in November
NMRA

GlobeNewswire

6 days ago

Neumora Therapeutics to Participate in Upcoming Conferences in November

Neumora Therapeutics (NMRA): Evaluating Valuation Following Dual Pipeline Advances in Psychiatry and Obesity
NMRA

Simply Wall St.

9 days ago

Neumora Therapeutics (NMRA): Evaluating Valuation Following Dual Pipeline Advances in Psychiatry and Obesity

Needham Lifts PT on Neumora Therapeutics (NMRA) to $8 From $6, Keeps a Buy Rating
NMRA

Insider Monkey

9 days ago

Needham Lifts PT on Neumora Therapeutics (NMRA) to $8 From $6, Keeps a Buy Rating

NMRA

MT Newswires

10 days ago

Neumora Therapeutics Insider Bought Shares Worth $4,999,977, According to a Recent SEC Filing

Undervalued Opportunities: 3 Penny Stocks With Market Caps Above $30M
NMRA

Simply Wall St.

6 months ago

Undervalued Opportunities: 3 Penny Stocks With Market Caps Above $30M

NMRA

GuruFocus.com

6 months ago

Neumora Therapeutics Inc (NMRA) Q1 2025 Earnings Call Highlights: Advancing Brain Disease ...

Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
NMRA

GlobeNewswire

6 months ago

Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Will Neumora Therapeutics (NASDAQ:NMRA) Spend Its Cash Wisely?
NMRA

Simply Wall St.

6 months ago

Will Neumora Therapeutics (NASDAQ:NMRA) Spend Its Cash Wisely?

Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025
NMRA

GlobeNewswire

6 months ago

Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

Former Neumora CEO to lead Galapagos spinout
NMRA

BioPharma Dive

7 months ago

Former Neumora CEO to lead Galapagos spinout

NMRA

MT Newswires

8 months ago

William Blair Downgrades Neumora Therapeutics to Market Perform From Outperform

JNJ Halts Development of Depression Drug Over Efficacy Concerns
NMRA

Zacks

8 months ago

JNJ Halts Development of Depression Drug Over Efficacy Concerns

J&J drops Phase III MDD programme due to lack of efficacy
NMRA

Clinical Trials Arena

8 months ago

J&J drops Phase III MDD programme due to lack of efficacy

NMRA

MT Newswires

8 months ago

Stifel Downgrades Neumora Therapeutics to Hold From Buy, Adjusts Price Target to $2 From $6

J&J scraps depression testing for potential blockbuster drug
NMRA

BioPharma Dive

8 months ago

J&J scraps depression testing for potential blockbuster drug

Neumora Therapeutics to Present at Leerink Global Healthcare Conference
NMRA

GlobeNewswire

8 months ago

Neumora Therapeutics to Present at Leerink Global Healthcare Conference

Neumora bids farewell to R&D head; Biohaven’s ‘one step forward, one step back’ data
NMRA

BioPharma Dive

8 months ago

Neumora bids farewell to R&D head; Biohaven’s ‘one step forward, one step back’ data

NMRA

MT Newswires

8 months ago

Stifel Adjusts Price Target on Neumora Therapeutics to $6 From $26, Maintains Buy Rating

Neumora Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
NMRA

GlobeNewswire

8 months ago

Neumora Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

NMRA

MT Newswires

8 months ago

Mizuho Securities Adjusts Neumora Therapeutics Price Target to $4 From $20, Maintains Outperform Rating

3 US Penny Stocks With Market Caps Below $400M
NMRA

Simply Wall St.

9 months ago

3 US Penny Stocks With Market Caps Below $400M

Neumora shakes up its C-suite; Biogen cuts early-stage pipeline
NMRA

BioPharma Dive

9 months ago

Neumora shakes up its C-suite; Biogen cuts early-stage pipeline

NMRA

MT Newswires

9 months ago

Neumora Therapeutics Names Paul Berns as CEO, Michael Milligan as CFO

Neumora Therapeutics Announces Leadership Transition
NMRA

GlobeNewswire

9 months ago

Neumora Therapeutics Announces Leadership Transition

3 US Penny Stocks With Market Caps Over $30M To Watch
NMRA

Simply Wall St.

10 months ago

3 US Penny Stocks With Market Caps Over $30M To Watch

Biotech Stock Roundup: NMRA Plunges on Study Failure, HOTH, VIR Soar on Study Data & More
NMRA

Zacks

10 months ago

Biotech Stock Roundup: NMRA Plunges on Study Failure, HOTH, VIR Soar on Study Data & More

Neumora shares look oversold after 80% drop, says Mizuho
NMRA

TipRanks

10 months ago

Neumora shares look oversold after 80% drop, says Mizuho

NMRA

MT Newswires

10 months ago

Sector Update: Health Care Stocks Rise in Late Afternoon Trading

NMRA

MT Newswires

10 months ago

Sector Update: Health Care Stocks Higher Friday Afternoon

NMRA

MT Newswires

10 months ago

Neumora Has 2 More Chances With Navacaprant After Readout Miss, Mizuho Says

Neumora Stock Hits Record Low on Depression Drug Study Failure
NMRA

Zacks

10 months ago

Neumora Stock Hits Record Low on Depression Drug Study Failure

Neumora Therapeutics’ navacaprant did not meet primary endpoint in depression
NMRA

TipRanks

10 months ago

Neumora Therapeutics’ navacaprant did not meet primary endpoint in depression

Results are in for a new depression drug trial, and they're cratering this stock
NMRA

Quartz

10 months ago

Results are in for a new depression drug trial, and they're cratering this stock

NMRA

MT Newswires

10 months ago

Sector Update: Health Care Stocks Ease Thursday Afternoon

NMRA

MT Newswires

10 months ago

Top Midday Decliners

Neumora Nosedives 80% At Pre-Market on Failed Depression Drug Trial
NMRA

Insider Monkey

10 months ago

Neumora Nosedives 80% At Pre-Market on Failed Depression Drug Trial

Neumora shares sink following Phase III flop in MDD
NMRA

Pharmaceutical Technology

10 months ago

Neumora shares sink following Phase III flop in MDD

NMRA

MT Newswires

10 months ago

--RBC Downgrades Neumora Therapeutics to Sector Perform From Outperform, Price Target is $4

Neumora Therapeutics Stock Crashes 83% After Depression Drug Flops
NMRA

Investor's Business Daily

10 months ago

Neumora Therapeutics Stock Crashes 83% After Depression Drug Flops

NMRA

MT Newswires

10 months ago

Sector Update: Health Care

Neumora Therapeutics Depression Drug Fails In First Of Three Pivotal Phase 3 Trials
NMRA

Benzinga

10 months ago

Neumora Therapeutics Depression Drug Fails In First Of Three Pivotal Phase 3 Trials

Neumora Plunges After Depression Drug Fails in Final-Stage Study
NMRA

Bloomberg

10 months ago

Neumora Plunges After Depression Drug Fails in Final-Stage Study

NMRA

MT Newswires

10 months ago

Neumora Therapeutics' Phase 3 Trial of Navacaprant in Major Depressive Disorder Fails to Meet Primary Endpoint; Shares Plunge

Neumora Therapeutics Reports Data from KOASTAL-1 Study of Navacaprant in Major Depressive Disorder
NMRA

GlobeNewswire

10 months ago

Neumora Therapeutics Reports Data from KOASTAL-1 Study of Navacaprant in Major Depressive Disorder

Neumora Therapeutics, Inc. (NMRA): This Small-Cap Stock Is Ready To Explode
NMRA

Insider Monkey

a year ago

Neumora Therapeutics, Inc. (NMRA): This Small-Cap Stock Is Ready To Explode

NMRA

MT Newswires

a year ago

Neumora Therapeutics Q3 Loss Narrows

Neumora Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
NMRA

GlobeNewswire

a year ago

Neumora Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Neumora Therapeutics to Participate in Upcoming Conferences in November
NMRA

GlobeNewswire

a year ago

Neumora Therapeutics to Participate in Upcoming Conferences in November

NMRA

MT Newswires

a year ago

JPMorgan Downgrades Neumora Therapeutics to Neutral, $15 Price Target

Neumora Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
NMRA

GlobeNewswire

a year ago

Neumora Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

NMRA

MT Newswires

a year ago

Neumora Therapeutics Insider Sold Shares Worth $370,962, According to a Recent SEC Filing

Neumora Therapeutics (NASDAQ:NMRA) Is In A Good Position To Deliver On Growth Plans
NMRA

Simply Wall St.

a year ago

Neumora Therapeutics (NASDAQ:NMRA) Is In A Good Position To Deliver On Growth Plans

Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders
NMRA

GlobeNewswire

a year ago

Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders

NMRA

MT Newswires

a year ago

Neumora Therapeutics Shares Decline After Q2 Results

Neumora Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
NMRA

GlobeNewswire

a year ago

Neumora Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

NMRA

MT Newswires

a year ago

Needham Initiates Neumora Therapeutics With Buy Rating, $23 Price Target

NMRA

MT Newswires

a year ago

Mizuho Securities Initiates Neumora Therapeutics at Outperform With $20 Price Target

10 clinical trials to watch in the second half of 2024
NMRA

BioPharma Dive

a year ago

10 clinical trials to watch in the second half of 2024

Neumora Therapeutics Announces Initiation of Phase 1b Study of NMRA-511 for Treatment of Alzheimer’s Disease Agitation
NMRA

GlobeNewswire

a year ago

Neumora Therapeutics Announces Initiation of Phase 1b Study of NMRA-511 for Treatment of Alzheimer’s Disease Agitation

This Neumora Therapeutics Insider Increased Their Holding In The Last Year
NMRA

Simply Wall St.

a year ago

This Neumora Therapeutics Insider Increased Their Holding In The Last Year

NMRA

MT Newswires

a year ago

Neumora Therapeutics Begins Phase 2 Study of Navacaprant in Bipolar Depression

Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression
NMRA

GlobeNewswire

a year ago

Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression

NMRA

MT Newswires

2 years ago

Neumora Therapeutics Shares Fall as Q1 Loss Narrows

Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
NMRA

GlobeNewswire

2 years ago

Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Neumora Therapeutics to Participate in Upcoming Conferences in May
NMRA

GlobeNewswire

2 years ago

Neumora Therapeutics to Participate in Upcoming Conferences in May

We're Hopeful That Neumora Therapeutics (NASDAQ:NMRA) Will Use Its Cash Wisely
NMRA

Simply Wall St.

2 years ago

We're Hopeful That Neumora Therapeutics (NASDAQ:NMRA) Will Use Its Cash Wisely

Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success
NMRA

Zacks

2 years ago

Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success

Neumora (NMRA) Down on FDA Clinical Hold on Neurology Drug
NMRA

Zacks

2 years ago

Neumora (NMRA) Down on FDA Clinical Hold on Neurology Drug

Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug
NMRA

Investor's Business Daily

2 years ago

Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug

Why Is Neurology Focused-Neumora Therapeutics Shares Trading Lower On Monday?
NMRA

Benzinga

2 years ago

Why Is Neurology Focused-Neumora Therapeutics Shares Trading Lower On Monday?

Neumora’s schizophrenia drug hit with clinical hold
NMRA

BioPharma Dive

2 years ago

Neumora’s schizophrenia drug hit with clinical hold

NMRA

Reuters

2 years ago

U.S. FDA places clinical hold on Neumora's schizophrenia drug study

Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study
NMRA

GlobeNewswire

2 years ago

Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study

institutional investors of Neumora Therapeutics, Inc. (NASDAQ:NMRA) must be disappointed after last week's 20% drop
NMRA

Simply Wall St.

2 years ago

institutional investors of Neumora Therapeutics, Inc. (NASDAQ:NMRA) must be disappointed after last week's 20% drop

Neumora Therapeutics to Participate at Stifel 2024 Virtual CNS Days
NMRA

GlobeNewswire

2 years ago

Neumora Therapeutics to Participate at Stifel 2024 Virtual CNS Days

Neumora Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
NMRA

GlobeNewswire

2 years ago

Neumora Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Google releases GenAI tools for music creation
NMRA

TechCrunch

2 years ago

Google releases GenAI tools for music creation

Encore Wire (WIRE) Sees a More Significant Dip Than Broader Market: Some Facts to Know
NMRA

Zacks

2 years ago

Encore Wire (WIRE) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Teladoc (TDOC) Stock Moves -1.57%: What You Should Know
NMRA

Zacks

2 years ago

Teladoc (TDOC) Stock Moves -1.57%: What You Should Know

NMRA

Reuters

2 years ago

Biden's job approval drops to 38% as border worries rise - Reuters/Ipsos

A Massive Problem With Apple Stock Today
NMRA

Motley Fool

2 years ago

A Massive Problem With Apple Stock Today

ITRI vs. AME: Which Stock Is the Better Value Option?
NMRA

Zacks

2 years ago

ITRI vs. AME: Which Stock Is the Better Value Option?

Jim Cramer is Bullish on These 10 Stocks
NMRA

Insider Monkey

2 years ago

Jim Cramer is Bullish on These 10 Stocks

Atkore Inc. Initiates Quarterly Dividend
NMRA

Business Wire

2 years ago

Atkore Inc. Initiates Quarterly Dividend

NMRA

Business Wire

2 years ago

Dillard’s, Citi and Mastercard Announce New Credit Card Agreements

25 Best Dividend Growth Stocks to Buy and Hold in 2024
NMRA

Insider Monkey

2 years ago

25 Best Dividend Growth Stocks to Buy and Hold in 2024

The S&P 500 Just Hit an All-Time High. Here's 1 Artificial Intelligence (AI) Stock to Buy and Hold Hand Over Fist.
NMRA

Motley Fool

2 years ago

The S&P 500 Just Hit an All-Time High. Here's 1 Artificial Intelligence (AI) Stock to Buy and Hold Hand Over Fist.

First Hawaiian, Inc. (NASDAQ:FHB) Q4 2023 Earnings Call Transcript
NMRA

Insider Monkey

2 years ago

First Hawaiian, Inc. (NASDAQ:FHB) Q4 2023 Earnings Call Transcript

Innovative Industrial Properties (IIPR) Gains As Market Dips: What You Should Know
NMRA

Zacks

2 years ago

Innovative Industrial Properties (IIPR) Gains As Market Dips: What You Should Know

INTERCORP FINANCIAL SERVICES, INC. TO HOST FOURTH QUARTER 2023 EARNINGS CONFERENCE CALL & VIDEO WEBCAST PRESENTATION
NMRA

PR Newswire

2 years ago

INTERCORP FINANCIAL SERVICES, INC. TO HOST FOURTH QUARTER 2023 EARNINGS CONFERENCE CALL & VIDEO WEBCAST PRESENTATION

NMRA

Thomson Reuters StreetEvents

2 years ago

Q4 2023 Cathay General Bancorp Earnings Call

7 Battery Stocks to Turn $100,000 Into $1 Million: January 2024
NMRA

InvestorPlace

2 years ago

7 Battery Stocks to Turn $100,000 Into $1 Million: January 2024

NMRA

GuruFocus.com

2 years ago

Cathay General Bancorp (CATY) Reports Full Year and Q4 2023 Earnings

NMRA

Associated Press Finance

2 years ago

Cathay: Q4 Earnings Snapshot

Cathay General Bancorp Announces Fourth Quarter and Full Year 2023 Results
NMRA

Business Wire

2 years ago

Cathay General Bancorp Announces Fourth Quarter and Full Year 2023 Results

5 Top Stocks to Gain as Consumer Confidence Buoys Up
NMRA

Zacks

2 years ago

5 Top Stocks to Gain as Consumer Confidence Buoys Up

NMRA

Business Wire

2 years ago

Dillard’s to Donate more than $245,000 to local RMHC Chapters through sale of Southern Living Christmas Cookbook

NMRA

Associated Press Finance

2 years ago

United Community Banks: Q4 Earnings Snapshot

Share on Social Networks: